/ Unknown statusPhase 2IIT Transdermal Testosterone Nanoemulsion Effects Emergent Loss of Libido in Women: A Randomized, Double-Blind, Placebo-Controlled Trial
This is a double-blind, randomized, placebo-controlled study. Seventy women, aged 35-75 years, with treatment-emergent loss of libido will be randomly allocated to the treatment with a Transdermal nanoemulsion of Testosterone (500mcg) delivering 300 mcg of testosterone/day or an identical placebo nanoemulsion (PLA) for 12 weeks.
100 Clinical Results associated with Lemos Laboratorio de Analises Clinicas S/C Ltda.
0 Patents (Medical) associated with Lemos Laboratorio de Analises Clinicas S/C Ltda.
100 Deals associated with Lemos Laboratorio de Analises Clinicas S/C Ltda.
100 Translational Medicine associated with Lemos Laboratorio de Analises Clinicas S/C Ltda.